Search Results 1001-1010 of 16986 for pharmacogenetics
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The goal of this study is to evaluate the use of immunostains during Mohs micrographic surgery (MMS) will improve detection of negative surgical margins in ...
The study will monitor adverse effects, evaluate symptom changes using PROMIS – Cancer Bank v1.0 assessments (Anxiety, Depression, Fatigue), and determine VR's ...
To evaluate patient and provider satisfaction with the automated GA delivery process. To identify barriers and facilitators to implementation based on survey ...
Integrative medicine combines complementary and alternative medicine (CAM) practices with conventional medicine.
About this study. Primary Objective: - Part A: To evaluate the safety of SAR650984 (isatuximab) in patients with relapsed/refractory multiple myeloma (RRMM) ...
The collected tissue specimens will be used to develop preclinical models; i.e., cell lines, patient derived micro-cancer models as well as patient-derived ...
EAU CLAIRE, Wis. — Your genes play a role in nearly all areas of your health. A gene is like an instruction manual for your body that tells your body how to ...
About this study. This is a multicenter, randomized, double-blind, parallel group, chronic-dosing (24 weeks), placebo-controlled study to assess the ...
The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.